gadofosveset trisodium has been researched along with optimark in 2 studies
| Studies (gadofosveset trisodium) | Trials (gadofosveset trisodium) | Recent Studies (post-2010) (gadofosveset trisodium) | Studies (optimark) | Trials (optimark) | Recent Studies (post-2010) (optimark) |
|---|---|---|---|---|---|
| 265 | 32 | 145 | 74 | 12 | 26 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barboriak, DP; Dale, BM; Merkle, EM | 1 |
| Kay, J; Todd, DJ | 1 |
1 review(s) available for gadofosveset trisodium and optimark
| Article | Year |
|---|---|
Gadolinium-Induced Fibrosis.
Topics: Animals; Contrast Media; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Meglumine; Nephrogenic Fibrosing Dermopathy; Organometallic Compounds; Terminology as Topic | 2016 |
1 other study(ies) available for gadofosveset trisodium and optimark
| Article | Year |
|---|---|
Gain in signal-to-noise for first-pass contrast-enhanced abdominal MR angiography at 3 Tesla over standard 1.5 Tesla: prediction with a computer model.
Topics: Abdomen; Adult; Computer Simulation; Contrast Media; Dose-Response Relationship, Drug; Female; Gadolinium; Gadolinium DTPA; Heterocyclic Compounds; Humans; Image Enhancement; Magnetic Resonance Angiography; Magnetics; Male; Meglumine; Middle Aged; Models, Biological; Organometallic Compounds; Predictive Value of Tests; Signal Processing, Computer-Assisted | 2007 |